- 保護されていない左冠動脈主幹部 unprotected left main coronary artery
English Journal
- Is percutaneous coronary intervention of unprotected left main coronary artery via transradial approach feasible for skilled transfemoral operators? Initial experience in an unselected population.
- Tomassini F, Gagnor A, Montali N, Gambino A, Bollati M, Infantino V, Tizzani E, Varbella F.SourceDepartment of Cardiology, Infermi Hospital, Rivoli, Italy. Electronic address: tomascard.tomassini@gmail.com.
- Cardiovascular revascularization medicine : including molecular interventions.Cardiovasc Revasc Med.2013 Jul-Aug;14(4):193-6. doi: 10.1016/j.carrev.2013.04.007. Epub 2013 Jun 13.
- BACKGROUND: The feasibility and efficacy of percutaneous coronary intervention (PCI) of unprotected left main coronary artery (ULMCA) via transradial access (TRA) is still a matter of concern, mainly in an unselected population.METHODS: We collected data about all PCI performed in patients with ULMC
- PMID 23768506
- Comparison of 5-Year Outcomes in Patients With and Without Unprotected Left Main Coronary Artery Disease After Treatment With Sirolimus-Eluting Stents: Insights From the j-Cypher Registry.
- Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Nishikawa H, Nakao K, Shirota K, Kawai K, Hiasa Y, Kadota K, Nozaki Y, Isshiki T, Sone T, Mitsudo K; j-Cypher Registry Investigators.SourceWakayama Medical Center, Wakayama, Japan.
- JACC. Cardiovascular interventions.JACC Cardiovasc Interv.2013 Jul;6(7):654-63. doi: 10.1016/j.jcin.2013.03.015.
- OBJECTIVES: This study assessed 5-year outcomes after implantation of sirolimus-eluting stents (SES) for unprotected left main coronary artery (ULMCA) disease in comparison with that for non-left main disease.BACKGROUND: More information on long-term outcomes after ULMCA stenting is needed.METHODS:
- PMID 23866178
- New-generation drug-eluting stent experience in the percutaneous treatment of unprotected left main coronary artery disease: the NEST registry.
- Bernelli C, Chieffo A, Buchanan GL, Montorfano M, Carlino M, Latib A, Figini F, Takagi K, Naganuma T, Maccagni D, Colombo A.SourceInterventional Cardiology Unit, San Raffaele Hospital, Via Olgettina 60 20132 Milan, Italy. chiarabernelli@yahoo.it
- The Journal of invasive cardiology.J Invasive Cardiol.2013 Jun;25(6):269-75.
- OBJECTIVES: To explore the 2-year clinical outcomes in patients with unprotected left main coronary artery (ULMCA) disease treated with overall new drug-eluting stent (DES) options.BACKGROUND: Recent available data have shown the feasibility and the safety of new DESs, mainly evaluating the everolim
- PMID 23735351
Japanese Journal
- Role of Bare-Metal Stents for Left Main Coronary Artery Disease in the Era of Drug-Eluting Stents : Which Coronary Stent Should Be Used for Left Main Trunk Disease? BMS or DES? (BMS-Side)
- KANEKO Hironori,KIJIMA Mikihiro
- Circulation journal : official journal of the Japanese Circulation Society 75(5), 1243-1249, 2011-04-25
- … In the past, coronary artery bypass graft surgery has been applied to revascularization for unprotected left main coronary artery (ULMCA) disease. … In recent years, due to the advent of drug-eluting stents (DES), restenosis rates have decreased in comparison to conventional bare-metal stents (BMS), and the range of applications of percutaneous coronary intervention (PCI) for ULMCA disease has been expanded. …
- NAID 10028147925
- Inter- and Intra-Observer Variability for Assessment of the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Score and Association of the SYNTAX Score With Clinical Outcome in Patients Undergoing Unprotected Left Main Stenting in the Real World
- SHIOMI Hiroki,TAMURA Toshihiro,NIKI Shunichiro,TADA Tomohisa,TAZAKI Junichi,TOMA Masanao,ONO Koh,SHIOI Tetsuo,MORIMOTO Takeshi,AKAO Masaharu,FURUKAWA Yutaka,NAKAGAWA Yoshihisa,KIMURA Takeshi
- Circulation journal : official journal of the Japanese Circulation Society 75(5), 1130-1137, 2011-04-25
- … However, the reproducibility of assessment for the SYNTAX score in unprotected left main coronary artery (ULMCA) disease has not yet been adequately evaluated. … The purpose of this study is to assess inter- and intra-observer variability for the assessment of the SYNTAX score in patients undergoing ULMCA stenting in daily clinical practice. …
- NAID 10028147497
- Comparison of Drug-Eluting Stent With Bare Metal Stent for Distal De Novo Unprotected Left Main Coronary Artery Stenosis : A Propensity Score-Matched Cohort Study
- HSUEH Shu-Kai,WU Chiung-Jen,FANG Hsiu-Yu,HSIEH Yuan-Kai,FANG Chih-Yuan,CHEN Chien-Jen,CHEN Shyh-Ming,YANG Cheng-Hsu,YIP Hon-Kan,CHEN Mien-Cheng,FU Morgan,CHENG Cheng-I
- Circulation journal : official journal of the Japanese Circulation Society 75(2), 290-298, 2011-01-25
- … <b><i>Background:</i></b> Percutaneous coronary intervention (PCI) with stent implantation is now considered a safe and feasible treatment for stenosis of the unprotected left main coronary artery (ULMCA). … Because few studies have focused on de novo distal ULMCA lesions, a propensity score-matched cohort study was conducted to compare bare metal stents (BMS) with drug-eluting stents (DES) for long-term outcomes following PCI. …
- NAID 10027426737
Related Links
- 2008年3月29日～4月1日Chicago U.S.A. 非保護左主冠動脈（ULMCA）内の分岐冠動脈病変（BCL）に薬剤溶出ステント（DES）を留置する前に、方向性冠動脈粥腫切除術（DCA）を導入する方法で、有用性と安全性が確認された。多施設で行われた ...
- I．緒 言 非保護冠動脈左主幹部（ULMCA）疾患の治療は，冠動脈 バイパス術（CABG）が，薬物療法に比べ生存率を改善する データが示されている1） ことから，第一選択とされる．し かし，ステントの出現により，ULMCA治療 ...
- 本研究における主要目的は、本邦における保護されていない左冠動脈主幹部（ULMCA）およびULMCAを含む病変に対し、エベロリムス溶出ステントを用いた経皮的冠動脈インターベンション（PCI）による治療を受けた患者における、手技後 ...
Related Pictures
